Glaucoma Webinar Still Available!

July 27, 2017

CE imageDon’t miss an opportunity to earn 2 hours of Category 1 CE credit toward your MOC! Diplomates and active candidates who were unable to attend the July 19th webinar “Advances in Diagnosis and Treatment of Glaucoma,” have a second chance to benefit from this excellent presentation by Dr. Mitchell Dul. The video recording is available through GoToWebinar until August 10th. Register and view the recording before then and receive full credit toward your MOC.

Over 150 optometrists attended the live webinar and the feedback was overwhelmingly positive.

“It exceeded my expectations!  Wonderfully up to date, informative, practical.”

“Great speaker! New, valuable info given (even for an OD practicing in MA where we cannot treat glaucoma).”

“It was a great lecture, and very easy to follow. Great glaucoma review.”

To access the video, click here, and log into GoToWebinar.

I'M A DIPLOMATE/CANDIDATE

LEARNING BUILDER ACCOUNT ACCESS

Check Board Certification Status

By going through the voluntary process of becoming board certified, our Diplomates demonstrate competence beyond entry level.

Upcoming Events

Stay in the know about exams, training, and more by visiting our events page.

Annual Board of Directors Meeting

Jun 16, 2026
The ABO Board of Directors will hold its annual meeting in Phoenix, Arizona on Tuesday, June 16th. The Board gathers...
More About Event > about Annual Board of Directors Meeting

Optometry’s Meeting

Jun 17, 2026 @ 7:00 pm - Jun 19, 2026 @ 4:00 pm CDT
Visit ABO at Optometry's Meeting in Phoenix, Arizona! We will be at booth 1232 starting Wednesday evening, June17 through Friday,...
More About Event > about Optometry’s Meeting

Webinar: The Updated Lab Work Primer

Jul 29, 2026 @ 7:00 pm - 9:00 pm CDT
Please join us for our summer webinar, The Updated Lab Work Primer,  presented by Meghan Elkins, OD. This course reviews...
More About Event > about Webinar: The Updated Lab Work Primer

SUBSCRIBE TO OUR NEWSLETTER

  • This field is for validation purposes and should be left unchanged.